Hewes L. Becker

CIK 00018401102 companiesWALTHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001840110

Recent Transactions

50 trades

Award
Galecto, Inc.$GLTO
Common Stock
2026-01-05+264,629→ 264,629 total
Award
Galecto, Inc.$GLTO
Stock Option (right to buy)
2026-01-05+528,603→ 528,603 total
Disposition from Tender
Blueprint Medicines Corp
Common Stock
2025-07-17−1,607→ 0 total
Award
Blueprint Medicines Corp
Common Stock
2025-07-17+21,353→ 51,772 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−19,271→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−9,115→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−26,125→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−22,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−25,000→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Stock Option (Right to Buy)
2025-07-17−13,490→ 0 total
Disposition to Issuer
Blueprint Medicines Corp
Common Stock
2025-07-17−50,165→ 1,607 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-06$87.98/sh−2,541→ 30,419 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-06$87.42/sh−2,691→ 32,960 total
Sale
Blueprint Medicines Corp
Common Stock
2025-03-05$88.80/sh−4,863→ 35,651 total
Award
Blueprint Medicines Corp
Common Stock
2025-03-01+11,000→ 40,514 total
Award
Blueprint Medicines Corp
Stock Options (Right to Buy)
2025-03-01+22,000→ 22,000 total
Sale
Blueprint Medicines Corp
Common Stock
2024-06-04$104.91/sh−2,424→ 29,514 total
Sale
Blueprint Medicines Corp
Common Stock
2024-06-03$106.43/sh−1,951→ 31,938 total
Sale
Blueprint Medicines Corp
Common Stock
2024-06-03$106.43/sh−2,971→ 33,889 total
Sale
Blueprint Medicines Corp
Common Stock
2024-05-31$105.81/sh−20,904→ 43,202 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Options (Right to Buy)
2024-05-31−10,573→ 13,490 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Options (Right to Buy)
2024-05-31−5,729→ 19,271 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-05-31$61.31/sh+8,385→ 65,239 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-05-31$66.24/sh+10,573→ 56,854 total
Sale
Blueprint Medicines Corp
Common Stock
2024-05-31$106.50/sh−3,191→ 64,106 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Options (Right to Buy)
2024-05-31−8,385→ 9,115 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2024-05-31$43.15/sh+5,729→ 70,968 total
Sale
Blueprint Medicines Corp
Common Stock
2024-05-31$107.86/sh−3,671→ 67,297 total
Sale
Blueprint Medicines Corp
Common Stock
2024-05-31$104.83/sh−6,342→ 36,860 total
Sale
Blueprint Medicines Corp
Common Stock
2024-03-07$90.69/sh−3,097→ 46,281 total
Award
Blueprint Medicines Corp
Stock Options (Right to Buy)
2024-03-01+25,000→ 25,000 total
Award
Blueprint Medicines Corp
Common Stock
2024-03-01+12,500→ 49,378 total
Sale
Blueprint Medicines Corp
Common Stock
2023-06-05$52.05/sh−1,404→ 36,878 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$45.72/sh−1,466→ 38,330 total
Sale
Blueprint Medicines Corp
Common Stock
2023-03-06$44.77/sh−48→ 38,282 total
Award
Blueprint Medicines Corp
Common Stock
2023-03-01+12,500→ 39,796 total
Award
Blueprint Medicines Corp
Stock Options (Right to Buy)
2023-03-01+25,000→ 25,000 total
Sale
Blueprint Medicines Corp
Common Stock
2022-06-07$60.00/sh−3,155→ 27,296 total
Sale
Blueprint Medicines Corp
Common Stock
2022-06-06$59.76/sh−1,220→ 30,451 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-16$60.00/sh−2,219→ 31,671 total
Sale
Blueprint Medicines Corp
Common Stock
2022-03-07$56.19/sh−1,047→ 33,890 total
Award
Blueprint Medicines Corp
Common Stock
2022-03-01+8,750→ 34,937 total
Award
Blueprint Medicines Corp
Stock Option (Right to Buy)
2022-03-01+17,500→ 17,500 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-12-15−729→ 24,063 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2021-12-15$66.24/sh+729→ 26,916 total
Sale
Blueprint Medicines Corp
Common Stock
2021-12-15$100.00/sh−729→ 26,187 total
Exercise/Conversion
Blueprint Medicines Corp
Stock Option (Right to Buy)
2021-11-15−729→ 24,792 total
Sale
Blueprint Medicines Corp
Common Stock
2021-11-15$115.49/sh−729→ 26,187 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2021-11-15$66.24/sh+729→ 26,916 total
Exercise/Conversion
Blueprint Medicines Corp
Common Stock
2021-10-15$66.24/sh+729→ 26,916 total

Companies

Recent Filings

Address

C/O GALECTO, INC., 221 CRESCENT ST, BUILDING 23, SUITE 105

WALTHAM, MA, 02453

View on SEC.gov